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In this work, we isolated and characterized mutants that overproduce threonine from Saccharomyces
cerevisiae. The mutants were selected for resistance to the threonine analog a-amino-13-hydroxynorvalerate(hydroxynorvaline), and, of these, the ones able to excrete threonine to the medium were chosen. The mutant
strains produce between 15 and 30 times more threonine than the wild type does, and, to a lesser degree, they
also accumulate isoleucine. Genetic and biochemical studies have revealed that the threonine overproduction
is, in all cases studied, associated with the presence in the strain of aHOM3 allele coding for a mutant aspartate
kinase that is totally or partially insensitive to feedback inhibition by threonine. This enzyme seems, therefore,
to be crucial in the regulation of threonine biosynthesis in S. cerevisiae. The results obtained suggest that this
strategy could be efficiently applied to the isolation of threonine-overproducing strains of yeasts other than S.
cerevisiae, even those used industrially.
In Saccharomyces cerevisiae, threonine and methionine
are synthesized from aspartate through a common metabolic
sequence that leads to homoserine in three steps. Homo-
serine is the branching point from which the pathways for
methionine and threonine diverge. The regulation of this
route takes place at a number of steps, both at the level of
enzyme synthesis and at the level of activity (for a review,
see reference 8). Threonine seems to be the primary com-
pound that regulates the carbon flow into and through the
common pathway, specifically at the level of aspartate
kinase and homoserine dehydrogenase, the first and third
enzymes of this route, respectively. Moreover, the flow into
each specific arm is controlled by end product inhibition of
the corresponding first enzymes: threonine inhibits the ho-
moserine kinase, while methionine inhibits the homoserine
O-acetyltransferase.
The regulation of an amino acid biosynthetic route can be
investigated by the use of amino acid analogs. Mutants that
are resistant to a toxic analog are good candidates to be
altered in their ability to regulate the synthesis of the natural
amino acid. In fact, many analogs have been used to isolate
amino-acid-overproducing strains, both in prokaryotes (1)
and in eukaryotes (15).
ot-Amino-,-hydroxyvaleric acid (hydroxynorvaline) is a
threonine analog known to inhibit bacterial growth mainly
because it mimics threonine and hinders the activity of the
threonine feedback-inhibited enzymes (4). As a conse-
quence, cells growing in the presence of hydroxynorvaline
produce smaller quantities of the amino acids synthesized
through this pathway, which can even become limiting for
growth. Hydroxynorvaline-resistant mutants have been iso-
lated from bacteria such as Eschenchia coli and Brevibacte-
num and Corynebactenum spp. (13). In these mutants, one
of the threonine-sensitive enzymes has become insensitive
to the feedback control by this amino acid and, as a
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consequence, the mutants overproduce to a certain degree
and even excrete threonine into the medium.
To our knowledge, hydroxynorvaline has never been
tested before in any yeast species. If the situation in this
organism was similar to that in bacteria, one would expect
that, in a certain hydroxynorvaline-resistant yeast strain,
one or more steps of the pathway would have been released
from threonine inhibition. Some of these mutants could also
overproduce and excrete threonine. The frequency at which
each kind of mutant arises and the degree of overproduction
of the amino acid would be indicative of the relative impor-
tance of that step in the control of the pathway. Additionally,
hydroxynorvaline resistance could also arise by a defect in
the permease that transports it into the cell.
In this work, we have isolated hydroxynorvaline-resistant
mutants from S. cerevisiae and have selected from among
them those able to excrete threonine into medium, which
indicates threonine overproduction. We have studied the
accumulation of threonine and other amino acids in the
mutant cells and characterized their defect both biochemi-
cally and genetically.
MATERIALS AND METHODS
Strains. The S. cerevisiae strains used are listed in Table 1.
Enzymes and chemicals. Hydroxynorvaline was a gift from
Degussa A.B.M. (Frankfurt, Germany); borrelidin was a
kind gift from K. Poralla; lactate dehydrogenase (EC
1.1.1.27), pyruvate kinase (EC 2.7.1.40) from rabbit muscle,
phosphoenol pyruvate, o-phthalaldehyde, and P-mercapto-
ethanol were from Sigma Chemical Co. (St. Louis, Mo.);
N-methyl-N'-nitro-N-nitrosoguanidine (NTG) was from Al-
drich Co. (Dorset, United Kingdom); all other biochemicals
were purchased from Sigma. Inorganic compounds were
from Merck AG (Darmstadt, Germany).
Media. Complete (YPD) medium, minimal (SD) medium,
and presporulation and sporulation media were prepared by
the methods of Sherman et al. (20). Minimal proline (SDP)
medium is identical to SD medium, except that L-proline
(0.1%) is used instead of ammonium sulfate (0.5%) as the
sole nitrogen source (6). Hydroxynorvaline toxicity was
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TABLE 1. S. cerevisiae strains used in this work
Strain(s) Genotype or phenotype Sourcea
D273-11A MATox adel hisl CSH
F4 MATa thr4 LCC
MMY1 MA Tot ura3D52 CyhR SERI
XCR13-5A MATa trpl-l lysl-l ura4 leu2 DGS
XCR28-4A MATa ura3 arg6 hom3 hisl DGS
AHV1 to AHV6 MATa trpl-l lysl-l ura4 Ieu2 This work
AhvR ThrE
YAHV1 MATa ura4 HOM3-RI This work
YAHV2 MATa HOM3-R2 This work
YAHV3 MATa HOM3-R3 This work
YAHV5 MATa ura3 HOM3-R5 This work
YAHV6 MATa ura3 HOM3-R6 This work
a Abbreviations: CSH, Cold Spring Harbor Laboratory (Cold Spring Har-
bor, N.Y.); LCC, La Cruz del Campo S.A. (Seville, Spain); SERI, Solar
Energy Research Institute (Golden, Colo.); DGS, Departamento de Genetica
y Biotecnia, Universidad de Sevilla (Seville, Spain).
tested in SDP plates containing 10 mM hydroxynorvaline.
Under these growth conditions, the MIC for the wild type
was found to be 2.5 mM. When necessary, minimal media
were supplemented with the appropriate requirements (20).
Mutagenesis. Early-stationary-phase cells of strain XCR13-
5A grown in YPD medium at 30°C were treated with NTG as
recommended by Calderon and Cerda-Olmedo (3). Under
these standard conditions, the survival rate of this strain was
approximately 40%.
Cross-feeding test for threonine excretion. Cells of the Thr-
strain F4 were grown to the stationary phase in YPD
medium, centrifuged, washed twice, and suspended in wa-
ter. A sample of this cell suspension, containing about 106
cells, was spread onto SD plates. The strains to be tested
were streaked onto this cell lawn with toothpicks, and the
plates were incubated at the temperatures stated for different
periods of time. The presence of a halo of F4 colonies
growing around a streak was considered a positive result.
Genetic analysis. Conventional procedures were used for
strain mating, diploid selection, and tetrad analysis (20).
Partial purification of the aspartate kinase. Aspartate ki-
nase was partially purified by the method of Ramos et al.
(16). The method is basically that described as follows.
Late-exponential-phase cells, grown at 30°C in SD medium,
were harvested and resuspended in AT buffer (40 mM
phosphate [pH 7.2], 0.1 M KCI, 5 mM MgCl2, 2 mM EDTA,
1 mM dithioerythritol 1 mM L-threonine [19]) and disrupted
in a Braun homogenizer with 0.5-mm-diameter glass beads.
Cell debris was removed by two consecutive centrifugations
at 4°C, the first for 20 min at 8,000 x g and the second one
for 2 h at 105,000 x g. Protamine sulfate (5 mg/g [wet
weight]), neutralized to pH 7 with NaOH, was added to the
crude extract, and, after 1 h of stirring at 4°C, the pellet was
removed by centrifugation. Ammonium sulfate was added,
and the fraction precipitating between 30 and 45% saturation
that contained the aspartate kinase activity was redissolved
in BT buffer (identical to AT buffer except that the phos-
phate concentration was 20 mM), dialyzed extensively
against the same buffer, and stored at -80°C.
Aspartate kinase assay. Aspartate kinase activity was
assayed as previously reported (16) by monitoring ADP
production by use of the pyruvate kinase-lactate dehydroge-
nase coupled assay described for the E. coli homoserine
kinase (2, 21), except that 10 mM ATP and 4 mM L-aspartate
were used as the substrates. One unit of activity was defined
as the amount of partially purified extract required to con-
vert 1 ,umol of ATP to ADP per min at 30°C. The standard
assay mixture contained the components described previ-
ously (19), with minor modifications. The reaction was
initiated by adding L-aspartate to the mixture. Protein con-
centrations were determined by the method of Lowry et al.
(9).
Amino acid determination. Amino acids were analyzed by
reverse-phase liquid chromatography by the method of Mar-
tinez-Force and Benitez (10). The system consisted of a
Waters high-performance liquid chromatograph with a
Novapack C-18 column (18 by 100 mm), two pumps, and a
Waters absorbance detector. An IBM AT computer with a
Baseline 810 chromatography workstation was used as the
controller, integrator, and data collector. The gradient pro-
gram consisted of two separate solvent mixtures. Solvent A
consisted of 20 mM sodium phosphate (pH 7.2), 1.5%
tetrahydrofuran, and 93.5% distilled water (by volume);
solvent B consisted of 10 mM sodium phosphate (pH 7.2),
55% acetonitrile, and 42.5% distilled water (by volume).
Amino acid samples were prepared as described previ-
ously (5). Samples (40 ml) of a late-exponential-phase culture
(optical density at 660 nm, approximately 0.7), were centri-
fuged. The supernatant was freeze-dried and resuspended in
1 ml of deionized water, and the suspension was filtered
through a 0.45-,um-pore-size Millipore filter and used to
measure excreted amino acids. To determine intracellular
amino acids, the pellet was resuspended in 2 ml of deionized
water and boiled for 15 min. A clear supernatant was
obtained after a brief centrifugation and a filtration as
described above.
Amino acids were derivatized by mixing 25 ml of each
suspension with 75 ml of the following mixture: 0.4 M
sodium borate (pH 10), 4.5 ml; 54 mg of o-phthalaldehyde
per ml of methanol, 0.5 ml (10).
RESULTS
Conditions for hydroxynorvaline toxicity test. Preliminary
experiments showed that hydroxynorvaline is toxic in media
with a poor nitrogen source such as proline but not in media
with a good nitrogen source such as ammonium sulfate (data
not shown). This is probably due to the fact that this
compound enters the yeast cell mainly through the general
amino acid permease (11), whose activity is both inhibited
and repressed by ammonium (6). Consequently, all of the
media in which hydroxynorvaline toxicity was to be tested
carried proline as the sole nitrogen source.
It was also found (data not shown) that the addition of
different amino acids such as threonine, homoserine, aspar-
agine, and citrulline to media containing hydroxynorvaline
counteracted its toxicity. The degree of this effect was
variable, probably depending on the mechanism involved in
each case. As expected from the proposed hydroxynorvaline
mode of action (4), threonine and homoserine, a threonine
precursor, improved the strain growth. It is very likely that
the threonine or homoserine addition bypasses the need for
the enzymes acting in this biosynthetic pathway, some of
which are inhibited by this drug (16). Consistent with this
view, it was found that, even though methionine alone had
no effect, the simultaneous addition of threonine and methi-
onine completely restored growth. Besides, these and other
amino acids may exert their influence at the transport level.
Citrulline, for instance, may compete with hydroxynorvaline
for the general amino acid permease, while others that serve
as good nitrogen sources (e.g., asparagine) may affect the
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FIG. 1. Quantities of amino acids accumulated (inside) and excreted to the medium (outside) by different AhvR ThrE strains. Symbols:
_, threonine inside; Eli, threonine outside; , isoleucine inside; W, methionine inside.
general amino acid permease activity, thus hindering its
entrance into the cell.
Isolation of hydroxynorvaline-resistant (AhVR) mutants.
Cells of the wild-type strain XCR13-5A were plated, either
directly or after nitrosoguanidine treatment, onto SDP me-
dium containing 10 mM hydroxynorvaline, and the plates
were incubated for 5 days. Spontaneous and NTG-induced
mutants arose among the survivors at frequencies of 1.5 x
10-6 and 5.0 x 10-5, respectively.
In S. cerevisiae, the excretion of an amino acid by a
certain strain usually indicates overproduction of this amino
acid. This criterion was applied to select candidates to
become threonine overproducers from the AhvR strains.
Thus, all AhvR colonies obtained were subjected to the
threonine cross-feeding test described in Materials and
Methods. While 60 of the 128 NTG-induced AhvR mutants
tested were threonine excretors (ThrE), none of the 60
spontaneous AhvR colonies were ThrE. We do not have a
plausible explanation for this difference. The AhvR ThrE
strains (designated by AHV followed by a number) were
used in further studies.
Dominance or recessiveness test. The dominance or reces-
siveness of the alleles responsible for the AhvR and ThrE
phenotypes with respect to the wild-type alleles was inves-
tigated by crossing the mutant strains with strain MMY1. All
of the resulting diploids were able to grow on SDP medium
containing 10 mM hydroxynorvaline, after 4 days of incuba-
tion at 30°C, proving the dominance of the mutant alleles. All
of them were also able to cross-feed the Thr- strain, i.e., to
excrete threonine, when incubated for 4 days at 37°C.
However, when incubated at 22°C, they showed a variety of
responses in the cross-feeding test: no diploid excreted
before 4 days of incubation, and while some presented an
excretion halo after 7 days, others did not, even after 11 days
of incubation. Five AH-V strains whose respective AHV/
MMY1 diploids showed different cross-feeding times at 22°C
were chosen for further characterization. The selected
strains were AHV1 (cross-feeding time, 7 days), AHV2 and
AHV3 (cross-feeding times, 9 days), AHV5 (cross-feeding
time, 11 days), and AHV6 (no cross-feeding observed after
11 days of incubation).
Accumulation of amino acids by the mutant strains. To
establish whether the AhvR ThrE strains were, in fact,
threonine overproducers, the quantities of this and other
amino acids accumulated and excreted into the medium by
these strains were investigated. The results (Fig. 1) show
that all of them accumulate 15 to 30 times more threonine
and excrete about 3 times more threonine than the parental
strain. They also contain more isoleucine, an amino acid that
derives from threonine, than the control does. Both in the
mutants and in the parental strain, the accumulated isoleu-
cine seems to be proportional to that of threonine (about 1:5
to 1:3). However, the amount of methionine, whose biosyn-
thetic pathway shares several steps with that of threonine, is
similar to that of the control in all mutants.
Genetic characterization. The following experiments were
designed to determine how many genes are responsible for
the AhvR and ThrE phenotypes and to try to establish what
gene(s) is responsible for the threonine overproduction phe-
notype. Previous kinetic studies demonstrated that the as-
partate kinase plays a very important role in the regulation of
the pathway at the enzymatic activity level (16). Thus, we
first tried to prove if, at least in some cases, threonine
overproduction depends on the presence in the cell of a
mutant allele of the HOM3 gene, which codes for this
enzyme. This kind of test is usually carried out by meiotic
analysis of crosses between the mutant strain and a strain
carrying a known allele, in this case, hom3. However, such
a cross provides only partial information since the Hom3-
spores require the presence of homoserine in the medium.
This would interfere severely with the hydroxynorvaline
resistance test. Consequently, only Hom3+ spores are sus-
ceptible to such an analysis.
As stated above, the presence of amino acids in the
medium interferes with the hydroxynorvaline resistance
test. Thus, it was found necessary to eliminate as many
genetic markers as possible from the cross. AHV/MMY1
diploids were sporulated, and the resulting tetrads were
VOL. 58, 1992
1680 RAMOS AND CALDERON




YAHV2 x D273-11A ThrE_HISJ 26 0 0
Ahv-fHIS1 26 0 0
AhvR-ThrE 26 0 0
YAHV5 x D273-11A ThrE_HISJ 19 0 0
AhVR-HIS1 19 0 0
AhvR-ThrE 19 0 0
YAHV6 x D273-11A ThrE_HISJ 13 0 1
AhvR HIS1 13 0 1
AhvR-ThrE 14 0 0
a PD, parental ditype; NPD, nonparental ditype; T, tetratype.
TABLE 3. Effect of L-threonine and hydroxynorvaline on the
aspartate kinase activity of the AhvR ThrE strainsa
Inhibition (%) by:
Strain Sp act 0m(mU mg of protein-) 20 mM Hydroxy
L-Threonine Hyroxy-norvaline
XCR13-5A 188 90 91
AHV1 38 0 0
AHV2 45 0 0
AHV3 135 0 32
AHV5 37 0 0
AHV6 44 50 21
a Each value represents the mean of at least two experiments; the standard
deviation was, in all cases, around 15%.
DISCUSSION
dissected. Meiotic descendants from these diploids showing
an AhvR ThrE phenotype and either a Ura+ or Ura- pheno-
type were chosen and called YAHV (followed by the same
number as that of their parents). When analyzing this cross,
it could already be stated that, in all cases, the excretion of
threonine segregated in a 2+ :2- fashion, indicating the
monogenic nature of this character.
Strains YAHV1, YAHV2, and YAHV5 were crossed with
strain XCR28-4A (hom3). About 20 tetrads deriving from
each cross were dissected and analyzed. In these crosses,
the excretion of threonine also segregated in a 2+ :2-
fashion. Moreover, all of the ThrE spores were Hom3+ and
no recombinant Hom3+ ThrNE (threonine-nonexcreting)
spore was observed. This result suggests that hom3 and the
three mutations are allelic. Therefore, these mutations have
been designated HOM3R-1, HOM3R-2, and HOM3R-5.
This conclusion was further proven when AhvR ThrE
mutants were crossed with a strain carrying a hisl allele. The
genes HIS] and HOM3 are located in the S. cerevisiae map
at a distance of 2.5 centimorgans (12). This cross allowed us
to carry out whole-tetrad analysis.
Table 2 presents the results of the genetic analysis of the
crosses between the strains YAHV and D273-11A. It clearly
shows the close linkage between the markers studied. Thus,
we can infer that the overproduction of threonine depends
on the presence in these strains of mutant alleles of the
HOM3 gene.
Aspartate kinase activity in the mutants. Studies carried
out to determine the kinetic parameters of the aspartate
kinase showed that both substrates, ATP and L-aspartate,
displayed normal Michaelis-Menten saturation kinetics, with
Kms of 3.6 and 4 mM, respectively (16). It has also been
established that threonine very effectively inhibits the aspar-
tate kinase activity, 3 mM being the concentration required
for half-maximal inhibition (16). Of other amino acids tested,
only hydroxynorvaline inhibits this activity (16). These and
other studies suggest that the regulation of the aspartate
kinase of S. cerevisiae takes place mainly through feedback
inhibition by threonine (16). Thus, an alteration in this
enzyme, such as making possible the activity of the enzyme
but not its regulation by threonine, could cause overproduc-
tion of this amino acid. To test whether this was the case
with the AhvR ThrE mutants, their aspartate kinase was
partially purified and the effects of threonine and hydroxy-
norvaline on the activity were assayed. The results (Table 3)
show, in fact, that all mutants tested have an altered pattern
of inhibition by both amino acids.
In this article, we describe the isolation and characteriza-
tion of S. cerevisiae mutants resistant to the threonine
analog hydroxynorvaline. Among them, those able to cross-
feed a threonine auxotroph were chosen as candidates for
threonine overproduction. This criterion has proven to be
useful since all selected strains are, in fact, threonine over-
producers. However, a negative result in this biological test
does not necessarily mean that the strain produces the same
amount of threonine as, or less than, the wild type. It is
possible that even if a large amount of threonine is produced
per cell, either it is not excreted into the medium or the
amount produced and excreted is not enough to feed the
tester strain. It is also possible that the growth rate of the
strain is so low that the final biomass, and thus the total
production of threonine, is small. If so, one would expect a
continuous distribution of the AhvR mutants with respect to
threonine production; only those mutants producing and
excreting a certain level of threonine would be detected as
such in the test. In fact, when the cross-feeding test was
performed at 22°C, the heterozygotic AhvR Thr /wild type
diploids behaved very differently. However, this behavior
does not correlate with the threonine production of the
correspondent haploid strain; in fact, the AHV6/MMY1
diploid is the slowest excretor, despite the fact that AHV6 is
the best threonine producer. Moreover, no correlation was
found between the amount of threonine produced and the
amount excreted by the mutants: the amount of accumulated
threonine varied between 15 and 30 times more than that in
the wild type, while the quantity of excreted threonine was,
in all of the mutants, only about 3 times higher than that in
the wild type (Fig. 1). Thus, we can infer that the variety
found among the heterozygotic diploids in the cross-feeding
test is not due to true differences in excretion but is due to
differences in other factors such as growth rate or lysis of the
strain at that temperature. Since one of the parents of the
diploids is, in all cases, strain MMY1, such differences
should reflect differences between the AHV mutants. These
mutants may differ not only in their HOM3 allele but also in
the genetic background due to the indiscriminate action of
the nitrosoguanidine.
S. cerevisiae mutants able to excrete amino acids have
been isolated previously (15). In all cases studied, excretion
was shown to be a direct consequence of overproduction.
Two genes specifically affecting threonine excretion (TEX1
and TEX2) have been described (5). These genes are linked
neither to each other nor to HOM3 (5). Laboratory strains
seem to have different combinations of mutant and wild-type
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TEX alleles. The close relationship between overproduction
and excretion found in all of the genetic crosses carried out
in this work suggests that all strains used are isogenic with
respect to the TEX alleles, and, therefore, that this factor is
irrelevant to the interpretation of the results.
All AhvR ThrE mutants examined so far have an aspartate
kinase that is totally or partially insensitive to feedback
inhibition by threonine. Other authors, using different strat-
egies, have found similar results. Nass and Poralla (14)
isolated mutants resistant to the macrolide antibiotic borre-
lidin. Their mutants fell into four groups. Only one of them,
BOR1, corresponds to strains that overproduce threonine;
all BOR1 strains bear mutations in the HOM3 gene. Thus,
borrelidin is not adequate to obtain threonine-overproducing
strains, since most of the resistant mutants isolated do not
accumulate this amino acid. As expected, AHV mutants are
also resistant to 20 ,uM borrelidin (data not shown), and,
conversely, the BOR1 mutants tested (BOR1-1 and BORI-
III [see reference 14]) are resistant to hydroxynorvaline
(data not shown).
Delgado et al. (5) showed that it is possible to directly
isolate threonine-overproducing strains by reverting a
Hom3- mutant; all of the isolated strains had a feedback-
insensitive aspartate kinase. Given the mode of action of
hydroxynorvaline (4), one would expect to find, among the
AhvR ThrE strains, mutants in the enzymes susceptible to
feedback inhibition by threonine, namely, aspartate kinase,
homoserine dehydrogenase, and homoserine kinase. How-
ever, it has been reported that yeast aspartate kinase is much
more sensitive to inhibition by hydroxynorvaline than ho-
moserine kinase (16). Therefore, it is logical that only
mutants in the aspartate kinase were isolated. On the other
hand, no correlation was found between the degree of
sensitivity to feedback inhibition by threonine or hydroxy-
norvaline of the aspartate kinase and the production of
threonine (Table 3). This result could mean that the condi-
tions used to measure the inhibition do not totally reflect the
"in vivo" activity of the enzymes. Table 3 also shows that
the specific activity of the aspartate kinase in crude extracts
of mutants is smaller than that of the wild type. This effect
could be due to repression by threonine of the HOM3 gene,
but other causes cannot be dismissed. Thus, it appears that
the presence in the cell of a threonine-insensitive aspartate
kinase overcomes other constraints imposed on its activity,
that is, the regulation takes place mainly at the enzymatic
activity level.
AHV mutants accumulate homoserine to about the same
level as BORI mutants do (18), i.e., about 10 times more
than the wild type (data not shown). They also overproduce
isoleucine but to a lesser degree than threonine does (Fig. 1).
The regulation of the pathway leading from threonine to
isoleucine relies mainly on the ILV1 gene and its product
(L-threonine deaminase), which catalyzes the conversion of
threonine into ot-ketobutyrate (7). Isoleucine overproduction
in the mutants is probably due to the induction by threonine
of the gene CHAI coding for a catabolic L-serine (L-threo-
nine) deaminase (17). This enzyme can carry out the same
reaction as the anabolic threonine deaminase but is not
sensitive to feedback inhibition.
The mutants do not accumulate more methionine than the
wild type does, which indicates that the methionine-specific
part of the route is strictly controlled, as expected from the
reported strong inhibition and repression of the homoserine-
O-transacetylase exerted by methionine and S-adenosylme-
thionine (8). Conversely, and on the basis of the results
presented above, the last part of the threonine pathway
seems to play a secondary role in the regulation of the
biosynthesis of this amino acid.
The facts that all AhvR ThrE mutants isolated are threo-
nine overproducers and that the HOM3-R alleles are domi-
nant suggest that this strategy could be efficiently used for
the isolation of threonine-overproducing strains of industrial
yeast species.
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